# A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.

> **NCT06496893** · NA · NOT_YET_RECRUITING · sponsor: **Vedic Lifesciences Pvt. Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Pre Diabetes
- Type2 Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** IP 1200 mg per soft gel capsule
- **DIETARY_SUPPLEMENT:** Placebo Comparator: Placebo 1200 mg per soft gel capsule

## Key facts

- **NCT ID:** NCT06496893
- **Lead sponsor:** Vedic Lifesciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-25
- **Primary completion:** 2024-12-25
- **Final completion:** 2024-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06496893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06496893, "A Study to Assess Effect of Glucocil® on Metabolic Health in Individuals With Prediabetes and Type 2 Diabetes Mellitus.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06496893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*